智能胰岛素递送技术与内源性葡萄糖响应胰岛素类似物
本综述探讨了三种优化血糖控制和时间范围的策略:将连续葡萄糖监测(CGM)与递送设备耦合的闭环系统、葡萄糖响应性聚合物包裹胰岛素以及基于机制的激素修饰。这些创新旨在提供与血糖水平成比例的激素活性而无需外部监测,可能改善糖尿病患者的临床结局。
要点
- 闭环系统、葡萄糖响应聚合物和胰岛素类似物修饰是三大智能递送策略。
- 内源性葡萄糖响应胰岛素类似物通过可逆开关调节生物利用度或构象。
- 这些技术旨在减少高血糖和低血糖波动,优化血糖控制。
核心结论
- 智能胰岛素递送技术和内源性葡萄糖响应胰岛素类似物有望优化血糖控制并减少血糖波动。
研究设计与样本
- 综述文章,未报告系统检索范围或样本量。
主要发现
- 闭环系统算法、葡萄糖响应聚合物基质和基于胰岛素构象开关的仿生设计是主要创新方向。
- 胰岛素化学和制剂创新可能改善临床结局。
临床怎么用
- 临床可关注闭环系统和葡萄糖响应胰岛素类似物在1型和长病程2型糖尿病中的应用前景。
局限性
- 原文未报告具体研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Insulin replacement therapy for diabetes mellitus seeks to minimise excursions in blood glucose concentration above or below the therapeutic range (hyper- or hypoglycaemia). To mitigate acute and chronic risks of such excursions, glucose-responsive insulin-delivery technologies have long been sought for clinical application in type 1 and long-standing type 2 diabetes mellitus. Such 'smart' systems or insulin analogues seek to provide hormonal activity proportional to blood glucose levels without external monitoring. This review highlights three broad strategies to co-optimise mean glycaemic control and time in range: (1) coupling of continuous glucose monitoring (CGM) to delivery devices (algorithm-based 'closed-loop' systems); (2) glucose-responsive polymer encapsulation of insulin; and (3) mechanism-based hormone modifications. Innovations span control algorithms for CGM-based insulin-delivery systems, glucose-responsive polymer matrices, bio-inspired design based on insulin's conformational switch mechanism upon insulin receptor engagement, and glucose-responsive modifications of new insulin analogues. In each case, innovations in insulin chemistry and formulation may enhance clinical outcomes. Prospects are discussed for intrinsic glucose-responsive insulin analogues containing a reversible switch (regulating bioavailability or conformation) that can be activated by glucose at high concentrations.
引用
- Jarosinski MA, Dhayalan B, Rege N, et al. 'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues. Diabetologia. 2021. PMID: 33710398. doi:10.1007/s00125-021-05422-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。